The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review

被引：0
|
作者：
Endale Gebreegziabher Gebremedhn
Peter John Shortland
David Anthony Mahns
机构：
[1] Western Sydney University,School of Medicine
[2] Western Sydney University,School of Science and Health
来源：
BMC Cancer | / 18卷
关键词：
Colorectal cancer; Oxaliplatin; Acute neuropathy; Chronic neuropathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
    Nicolas Kerckhove
    David Tougeron
    Côme Lepage
    Denis Pezet
    Karine Le Malicot
    Manon Pelkowski
    Bruno Pereira
    David Balayssac
    BMC Cancer, 22
  • [42] Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer
    Teng, Christina
    Cohen, Jordan
    Egger, Sam
    Blinman, Prunella L.
    Vardy, Janette L.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (01) : 33 - 47
  • [43] Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
    Tsubota, Maho
    Fukuda, Ryotaro
    Hayashi, Yusuke
    Miyazaki, Takaya
    Ueda, Shin
    Yamashita, Rika
    Koike, Nene
    Sekiguchi, Fumiko
    Wake, Hidenori
    Wakatsuki, Shuji
    Ujiie, Yuka
    Araki, Toshiyuki
    Nishibori, Masahiro
    Kawabata, Atsufumi
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01) : 199
  • [44] Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
    Maho Tsubota
    Ryotaro Fukuda
    Yusuke Hayashi
    Takaya Miyazaki
    Shin Ueda
    Rika Yamashita
    Nene Koike
    Fumiko Sekiguchi
    Hidenori Wake
    Shuji Wakatsuki
    Yuka Ujiie
    Toshiyuki Araki
    Masahiro Nishibori
    Atsufumi Kawabata
    Journal of Neuroinflammation, 16
  • [45] Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report
    Soma, Yu
    Kawabe, Taiichi
    Kitaji, Daiyu
    Hoshino, Kaoru
    Sunohara, Sumire
    Iwano, Takehisa
    Kawano, Naomi
    BMC NEPHROLOGY, 2023, 24 (01)
  • [46] Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report
    Yu Soma
    Taiichi Kawabe
    Daiyu Kitaji
    Kaoru Hoshino
    Sumire Sunohara
    Takehisa Iwano
    Naomi Kawano
    BMC Nephrology, 24
  • [47] The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: Comparative study with celecoxib
    Abd-Elmawla, Mai A.
    Abdelalim, Eman
    Ahmed, Kawkab A.
    Rizk, Sherine M.
    LIFE SCIENCES, 2023, 315
  • [48] Efficacy and safety of traditional plant-based medicines for preventing chronic oxaliplatin-induced peripheral neurotoxicity in patients with colorectal cancer: A systematic review and meta-analysis with core herb contribution
    Han, Jierong
    Lai, Hengzhou
    Li, Wenyuan
    Liao, Huarui
    Xiao, Chong
    Li, Xueke
    You, Fengming
    Guo, Jing
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 326
  • [49] Efficacy of Oxaliplatin-based Chemotherapy plus Bevacizumab as First-line Treatment for Advanced Colorectal Cancer A Systematic Review and Pooled Analysis of Published Trials
    Petrelli, Fausto
    Coinu, Andrea
    Ghilardi, Mara
    Cabiddu, Mary
    Zaniboni, Alberto
    Barni, Sandro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (02): : 227 - 233
  • [50] Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis
    Sato, Miki Takenaka
    Hasegawa, Takeshi
    Noma, Hisashi
    Sugita, Hideki
    Ota, Erika
    BMJ OPEN, 2023, 13 (09):
12345